Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC
Conditions
- Colorectal Cancer
- PDAC - Pancreatic Ductal Adenocarcinoma
Interventions
- OTHER: Personalized Functional Profiling
Sponsor
Luxembourg Institute of Health
Collaborators